jpg", "id": "F1", "section_type": "FIG", "type": "fig_caption"}, "text": "(C) Altered sensitivity of RXRalpha LBD or GST-RXRalpha to chymotrypsin (mug/ml) by Sulindac (100 muM).", "sentences": [], "annotations": [], "relations": []}, {"offset": 36595, "infons": {"file": "nihms203815f1.jpg", "id": "F1", "section_type": "FIG", "type": "fig_caption"}, "text": "(D) Comparison of 19F NMR spectra of Sulindac (100 muM) in the absence and presence of 10 muM RXRalpha LBD or Nur77 protein.", "sentences": [], "annotations": [], "relations": []}, {"offset": 36720, "infons": {"file": "nihms203815f1.jpg", "id": "F1", "section_type": "FIG", "type": "fig_caption"}, "text": "(E, F) Sulindac inhibits transactivation of RXRalpha homodimers and heterodimers. (TREpal)2-tk-CAT (E) or betaRARE-tk-CAT (F), Nur77 and/or RXRalpha were transiently transfected into CV-1 cells. Cells were treated with or without SR11237 (10-6 M) in the presence or absence of Sulindac. CAT activity was determined.", "sentences": [], "annotations": [], "relations": []}, {"offset": 37036, "infons": {"file": "nihms203815f1.jpg", "id": "F1", "section_type": "FIG", "type": "fig_caption"}, "text": "One of three to five similar experiments is shown. Error bars represent SEM.", "sentences": [], "annotations": [], "relations": []}, {"offset": 37113, "infons": {"file": "nihms203815f1.jpg", "id": "F1", "section_type": "FIG", "type": "fig_caption"}, "text": "See also Figure S1.", "sentences": [], "annotations": [], "relations": []}, {"offset": 37133, "infons": {"file": "nihms203815f2.jpg", "id": "F2", "section_type": "FIG", "type": "fig_title_caption"}, "text": "Sulindac Induces RXRalpha-dependent Apoptosis and Bax Activation", "sentences": [], "annotations": [], "relations": []}, {"offset": 37198, "infons": {"file": "nihms203815f2.jpg", "id": "F2", "section_type": "FIG", "type": "fig_caption"}, "text": "(A-C) The apoptotic effects of Sulindac in F9 or F9 cells lacking RXRalpha (F9 RXRalpha-/-). Cells treated with Sulindac (75 muM) for 24 hr were analyzed by DAPI staining (A), PARP cleavage (B), and DNA fragmentation (C). Scale bar: 10 mum.", "sentences": [], "annotations": [], "relations": []}, {"offset": 37439, "infons": {"file": "nihms203815f2.jpg", "id": "F2", "section_type": "FIG", "type": "fig_caption"}, "text": "(D,E) RXRalpha siRNA inhibits apoptosis induction by Sulindac. H460 lung cancer cells transfected with control or RXRalpha siRNA were treated with Sulindac (75 muM) for 24 hr and analyzed by DAPI staining for apoptosis.", "sentences": [], "annotations": [], "relations": []}, {"offset": 37659, "infons": {"file": "nihms203815f2.jpg", "id": "F2", "section_type": "FIG", "type": "fig_caption"}, "text": "(F) Transfection of RXRalpha enhances the apoptotic effect of Sulindac. CV-1 cells transfected with GFP-RXRalpha were treated with Sulindac (75 muM) for 24 hr and analyzed by DAPI staining. GFP-RXRalpha-transfected cells underwent extensive nuclear fragmentation and condensation.", "sentences": [], "annotations": [], "relations": []}, {"offset": 37940, "infons": {"file": "nihms203815f2.jpg", "id": "F2", "section_type": "FIG", "type": "fig_caption"}, "text": "(G) Disruption of the RXRalpha LBP impairs the apoptotic effect of Sulindac. CV-1 cells transfected with GFP-RXRalpha or GFP-RXRalpha/F313S/R316E were treated with Sulindac (75 muM) for 24 hr and analyzed by DAPI staining. Apoptosis scored in receptor-transfected cells. See also Figure S2.", "sentences": [], "annotations": [], "relations": []}, {"offset": 38231, "infons": {"file": "nihms203815f2.jpg", "id": "F2", "section_type": "FIG", "type": "fig_caption"}, "text": "(H,I) Role of Bax in apoptosis induction by Sulindac. HCT116 cells or HCT116 cells lacking Bax (Bax-/-) were treated with or without sulindac (75 muM) for 24 hr. Apoptosis determined by PARP cleavage (H) and DAPI staining (I).", "sentences": [], "annotations": [], "relations": []}, {"offset": 38462, "infons": {"file": "nihms203815f2.jpg", "id": "F2", "section_type": "FIG", "type": "fig_caption"}, "text": "(J,K) RXRalpha siRNA inhibits sulindac-induced Bax activation. Knocking down RXRalpha in HCT116 cells by RXRalpha siRNA revealed by immunoblotting. HCT116 cells transfected with or without RXRalpha siRNA or control siRNA for 48 hr were treated with Sulindac for 6 hr, and analyzed for Bax oligomerization (J) and Bax conformational change and mitochondrial targeting by immunostaining/confocal microscopy using Bax/Delta21, Bax/6A7, or anti-Hsp60 antibody (K). About 60% of cells showed Bax conformational change presented.", "sentences": [], "annotations": [], "relations": []}, {"offset": 38986, "infons": {"file": "nihms203815f2.jpg", "id": "F2", "section_type": "FIG", "type": "fig_caption"}, "text": "One of three to five similar experiments is shown. Error bars represent SEM.